Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05176808 · ClinicalTrials.gov registry record · NA

Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

A NA study of Autism Spectrum Disorder and Autism, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
NA
Development phase
188
Enrollment target
1
Study location

NCT05176808: Recruiting NA study of Autism Spectrum Disorder and Autism, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

NCT05176808 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 188 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (40% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05176808, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
NA
Development phase
188 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this research study is to improve outcomes involving core social-communication symptoms for young children with ASD or social communication delays by increasing access to clinically validated early behavioral intervention through a telehealth parent coaching model. The investigators will test the hypothesis that telehealth-delivered Naturalistic Developmental Behavioral Intervention parent coaching (TC) is non-inferior to in-person coaching (IPC) for the treatment of core social-communication symptoms in toddlers with either a social communication delay or ASD.

Primary Outcome

10 minute caregiver/child play samples will be coded using an engagement coding schema. The schema differentiates different levels of engagement. This data will be used to compare duration of engagement states at pre- and post-testing.

Interventions

  • BEHAVIORAL Early Achievements- Parent Coaching Intervention

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2022-02-07
Est. Completion 2026-09-01
Phase NA

What NCT05176808 shows while recruiting

NCT05176808 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (40% higher).

The record links to 9 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Early Achievements- Parent Coaching Intervention is the first listed.

NCT05176808 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05176808 about?

NCT05176808 is a clinical study titled "Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)". The primary objective of this research study is to improve outcomes involving core social-communication symptoms for young children with ASD or social communication delays by increasing access to clinically validated early behavioral intervention through a telehealth parent coaching model. The inves...

What is the current status of trial NCT05176808?

This trial is currently recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2022-02-07. Estimated completion is 2026-09-01.

What conditions does trial NCT05176808 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Autistic Disorder, Asperger Syndrome, Active Autistic Disorder.

What interventions are being tested in trial NCT05176808?

The interventions under investigation include: Early Achievements- Parent Coaching Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05176808?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05176808 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05176808's enrollment target sits among peer trials

188 44th of 224 higher than 181 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422198 · 188 participants · Phase 3

    Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

  • NCT04469790 · 188 participants · NA

    Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children

  • NCT04671667 · 188 participants · Phase 2

    Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • NCT04853251 · 188 participants · Phase 4

    A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05176808, the US trial registry maintained by the National Library of Medicine. NCT05176808 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.